Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2025-12-24 @ 5:04 PM
NCT ID:
NCT06625450
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed cases of UC by endoscopy and biopsy
* Patients in clinical remission for at least 3 months on Tofacitinib and mesalamine
Exclusion Criteria:
* Incomplete evaluation
* Uncertain diagnosis
* Active disease
* Subjects with Crohn's disease, microscopic colitis and collegenous colitis or IBD-U
* Unwilling to participate in study
* Pregnant and lactating women or those who are planning pregnancy in the forthcoming 2 years
* Patients with any suspected or proven malignancy
* Subjects with severe comorbidities
* Prior history of venous thromboembolism.
* Subjects undergoing major surgery
* Myocardial infarction within previous 3 months
* Heart failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06625450
Study Brief:
Protocol Section:
NCT06625450